BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23965594)

  • 1. Bioreactors as engineering support to treat cardiac muscle and vascular disease.
    Massai D; Cerino G; Gallo D; Pennella F; Deriu MA; Rodriguez A; Montevecchi FM; Bignardi C; Audenino A; Morbiducci U
    J Healthc Eng; 2013; 4(3):329-70. PubMed ID: 23965594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioreactor technology in cardiovascular tissue engineering.
    Mertsching H; Hansmann J
    Adv Biochem Eng Biotechnol; 2009; 112():29-37. PubMed ID: 19290496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac tissue engineering: state of the art.
    Hirt MN; Hansen A; Eschenhagen T
    Circ Res; 2014 Jan; 114(2):354-67. PubMed ID: 24436431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial.
    Asnaghi MA; Jungebluth P; Raimondi MT; Dickinson SC; Rees LE; Go T; Cogan TA; Dodson A; Parnigotto PP; Hollander AP; Birchall MA; Conconi MT; Macchiarini P; Mantero S
    Biomaterials; 2009 Oct; 30(29):5260-9. PubMed ID: 19647867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreactors for cardiovascular cell and tissue growth: a review.
    Barron V; Lyons E; Stenson-Cox C; McHugh PE; Pandit A
    Ann Biomed Eng; 2003 Oct; 31(9):1017-30. PubMed ID: 14582605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new bioreactor adapts to materials state and builds a growth model for vascular tissue engineering.
    Couet F; Mantovani D
    Artif Organs; 2012 Apr; 36(4):438-45. PubMed ID: 22187974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated experimental-computational approach for the study of engineered cartilage constructs subjected to combined regimens of hydrostatic pressure and interstitial perfusion.
    Moretti M; Freed LE; Padera RF; Laganà K; Boschetti F; Raimondi MT
    Biomed Mater Eng; 2008; 18(4-5):273-8. PubMed ID: 19065033
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel bioreactor for ligament tissue engineering.
    Kahn CJ; Vaquette C; Rahouadj R; Wang X
    Biomed Mater Eng; 2008; 18(4-5):283-7. PubMed ID: 19065035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac cells implanted into a cylindrical, vascularized chamber in vivo: pressure generation and morphology.
    Birla RK; Dhawan V; Dow DE; Huang YC; Brown DL
    Biotechnol Lett; 2009 Feb; 31(2):191-201. PubMed ID: 18854950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human embryonic stem cell-derived mesodermal progenitors display substantially increased tissue formation compared to human mesenchymal stem cells under dynamic culture conditions in a packed bed/column bioreactor.
    de Peppo GM; Sladkova M; Sjövall P; Palmquist A; Oudina K; Hyllner J; Thomsen P; Petite H; Karlsson C
    Tissue Eng Part A; 2013 Jan; 19(1-2):175-87. PubMed ID: 22924642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of oxygen tension and pH in a bioreactor for cartilage tissue engineering.
    Das R; Kreukniet M; Oostra J; van Osch G; Weinans H; Jahr H
    Biomed Mater Eng; 2008; 18(4-5):279-82. PubMed ID: 19065034
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioreactors for connective tissue engineering: design and monitoring innovations.
    El Haj AJ; Hampson K; Gogniat G
    Adv Biochem Eng Biotechnol; 2009; 112():81-93. PubMed ID: 19290498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bioreactors in tissue engineering.
    Martin I; Wendt D; Heberer M
    Trends Biotechnol; 2004 Feb; 22(2):80-6. PubMed ID: 14757042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pulsatile hydrostatic pressure bioreactor for vascular tissue-engineered constructs.
    Shaikh FM; O'Brien TP; Callanan A; Kavanagh EG; Burke PE; Grace PA; McGloughlin TM
    Artif Organs; 2010 Feb; 34(2):153-8. PubMed ID: 19995361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular tissue engineering I. Perfusion bioreactors: a review.
    Mironov V; Kasyanov VA; Yost MJ; Visconti R; Twal W; Trusk T; Wen X; Ozolanta I; Kadishs A; Prestwich GD; Terracio L; Markwald RR
    J Long Term Eff Med Implants; 2006; 16(2):111-30. PubMed ID: 16700652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds.
    Jeong SI; Kwon JH; Lim JI; Cho SW; Jung Y; Sung WJ; Kim SH; Kim YH; Lee YM; Kim BS; Choi CY; Kim SJ
    Biomaterials; 2005 Apr; 26(12):1405-11. PubMed ID: 15482828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreactors for tissue engineering: focus on mechanical constraints. A comparative review.
    Bilodeau K; Mantovani D
    Tissue Eng; 2006 Aug; 12(8):2367-83. PubMed ID: 16968176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioreactors for tissue engineering.
    Chen HC; Hu YC
    Biotechnol Lett; 2006 Sep; 28(18):1415-23. PubMed ID: 16955350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell sheet engineering for the injured heart.
    Wu KH; Mo XM; Liu YL
    Med Hypotheses; 2008 Nov; 71(5):700-2. PubMed ID: 18703292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fundamentals of tissue engineering: scaffolds and bioreactors.
    Vunjak-Novakovic G
    Novartis Found Symp; 2003; 249():34-46; discussion 46-51, 170-4, 239-41. PubMed ID: 12708648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.